effectiveness of vitamin D in COPD

Phase 2

Recruiting

• Conditions: Chronic obstructive pulmonary disease.; Chronic obstructive pulmonary disease, unspecified; J44.9

• Registration Number: IRCT20190810044500N12
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Moderate to severe COPD patients
Vitamin D level less than 20ng/ml
age more than 18

Exclusion Criteria

age less than 18 years
Vitamin D level more than 20ng/ml
Mild COPD patients
patients with COPD exacerbation
pregnancy
lactation

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of people with chronic obstructive pulmonary disease. Timepoint: Before the start of the intervention and in the 2nd and 4th month of the start of treatment and after the end of treatment. Method of measurement: Blood sample.

Secondary Outcome Measures

Name	Time	Method
Quality of Life. Timepoint: Before the start of the intervention and in the 2nd and 4th month of the start of treatment and after the end of treatment. Method of measurement: questionnaire ( EORTC QLQ - C30 version 3).